Lauren Averett Byers Receives TAMEST O’Donnell Award for Lung Cancer Research
December 2024 – Lauren Averett Byers, M.D., professor of Thoracic/Head & Neck Medical Oncology at The University of Texas MD Anderson Cancer Center,... Read more.
Agilent Companion Diagnostic Assay PD-L1 IHC 28-8 pharmDx Receives European IVDR Certification
December 2024 – Agilent Technologies Inc. announced the issuing of a Class C companion diagnostic In Vitro Diagnostic Regulation (IVDR) certification for PD-L1... Read more.
FDA approves Bristol Myers Squibb’s Subcutaneous Opdivo Qvantig™ for various solid tumor indications
December 2024- Bristol Myers Squibb announced that the U.S. Food and Drug Administration (FDA) granted approval for Opdivo Qvantig™ (nivolumab and hyaluronidase-nvhy)... Read more.
Merck enters into exclusive global license agreement with Hansoh Pharma
December 2024- Merck, known as MSD outside of the United States and Canada, and Hansoh Pharma, a Chinese biopharmaceutical company, announced that they have entered... Read more.
UNM College of Nursing celebrates Fall 2024 award winners
December 2024- Three graduating University of New Mexico College of Nursing students were recognized with awards for their achievements at the Fall 2024 convocation,... Read more.
Northampton man receives UK’s first double-lung transplant with new machine
December 2024- A man from Northampton has become the first person in the UK to receive a double-lung transplant using a new machine that could improve the number... Read more.
Alfred Health becomes first in southern hemisphere to adopt GE HealthCare’s command center
December 2024- GE HealthCare announced that Alfred Health in Melbourne will be the first health service in the Southern Hemisphere to adopt GE HealthCare’s Command... Read more.
Roche debuts cobas® Mass Spec solution to advance diagnostic technology
Basel- December 2024- Roche announced that it has received CE mark approval for its cobas® Mass Spec solution including the cobas® i 601 analyser and the first... Read more.
Cosmos Health appoints professor Dimitrios Trafalis as head of oncology
December 2024- Cosmos Health, a diversified, vertically integrated global healthcare group engaged in innovative R&D, announced the appointment of Professor... Read more.
WHO issues alert on falsified IMFINZI injection in multiple countries
December 2024- The World Health Organization (WHO) has issued a medical product alert regarding a batch of falsified IMFINZI (durvalumab) injection, 500mg/10ml.... Read more.
